This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeFrock, J L
Right arrow Articles by Bihl, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LeFrock, J L
Right arrow Articles by Bihl, J

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1985 July; 28(1): 133-137

Comparative in vitro evaluation of cefpimizole (U-63196E), a new antipseudomonal cephalosporin.

J L LeFrock, B R Smith and J Bihl

ABSTRACT

The activity of cefpimizole (formerly U-63196E) was compared with that of other broad-spectrum cephalosporins and penicillins. Overall, cefpimizole exhibited limited activity against gram-positive cocci and members of the family Enterobacteriaceae as compared with the other cephalosporins tested. The activity of cefpimizole against Pseudomonas aeruginosa was similar to that of cefoperazone and mezlocillin (90% MIC, 32 micrograms/ml) but poorer than that of ceftazidime (90% MIC, 8 micrograms/ml). Cefpimizole appears to have no in vitro advantage over the cephalosporins with which it was compared.

Antimicrob Agents Chemother. 1985 July; 28(1): 133-137






Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»